B
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Recent Filings
- SC 13D/A143.8 KBBIOENVISION INCOct 1, 9:16 AM ET·0000950136-07-006779
- 8-K36.8 KBBIOENVISION INCAug 16, 1:28 PM ET·0001104659-07-063037
- 8-K16.5 KBBIOENVISION INCJul 30, 9:52 AM ET·0001104659-07-057030
- 424.8 KBBIOENVISION INCJul 12, 6:48 PM ET·0000950142-07-001594
- SC 13D/A46.6 KBBIOENVISION INCJul 12, 5:26 PM ET·0000950142-07-001590
- 45.3 KBBIOENVISION INCJul 12, 12:19 PM ET·0001116679-07-001828
- 45.3 KBBIOENVISION INCJul 12, 12:13 PM ET·0001116679-07-001826
- 45.3 KBBIOENVISION INCJul 12, 12:11 PM ET·0001116679-07-001824
- 45.3 KBBIOENVISION INCJul 12, 12:07 PM ET·0001116679-07-001822
- SC 13D/A98.0 KBBIOENVISION INCJul 3, 6:09 AM ET·0000950136-07-004627
Insiders
10- Abercrombie IanSales Director, Europe
- GENZYME CORP10% Owner
- LUCI DAVID PSee Exhibit 99.1
- Nelson Thomas ScottDirector
- PERSEUSPUR LLC10% Owner, See Footnotes (3) and (4)
- PERSEUS SOROS BIOPHARMACEUTICAL FUND LP10% Owner, Footnotes (1), (2), (3), (6)
- PERSEUS SOROS PARTNERS LLC10% Owner, Footnotes (1), (2), (3), (6)
- Rouhandeh Steven H10% Owner
- SCO CAPITAL PARTNERS LLC10% Owner
- SFM PARTICIPATION LP10% Owner, Footnotes (1), (2), (3), (6)
Tickers
No tickers on record
Addresses
business
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
mailing
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
Former Names
- ASCOT GROUP INC1999-01-12